Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Co-Diagnostics's gross margin for the twelve months ending Sep 30, 2026 was 20.3%. For fiscal 2025 it was 64.3%, against 74.5% the year before. The highest annual figure on record is 96.1% in fiscal 2017.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.3% | −10.2 |
| FY2024 | Dec 31, 2024 | 74.5% | +35.9 |
| FY2023 | Dec 31, 2023 | 38.6% | −45.4 |
| FY2022 | Dec 31, 2022 | 84.0% | −4.2 |
| FY2021 | Dec 31, 2021 | 88.2% | +10.4 |
| FY2020 | Dec 31, 2020 | 77.7% | +30.0 |
| FY2019 | Dec 31, 2019 | 47.7% | −28.8 |
| FY2018 | Dec 31, 2018 | 76.5% | −19.6 |
| FY2017 | Dec 31, 2017 | 96.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -7.2% | −89.2 |
| Q2 FY2026 | Jun 30, 2026 | 72.7% | −7.6 |
| Q1 FY2026 | Mar 31, 2026 | -32.8% | −89.8 |
| Q4 FY2025 | Dec 31, 2025 | 46.0% | +116.9 |
| Q3 FY2025 | Sep 30, 2025 | 81.9% | +28.3 |
| Q2 FY2025 | Jun 30, 2025 | 80.3% | −11.7 |
| Q1 FY2025 | Mar 31, 2025 | 57.1% | +7.2 |
| Q4 FY2024 | Dec 31, 2024 | -70.8% | −87.3 |
| Q3 FY2024 | Sep 30, 2024 | 53.6% | −36.0 |
| Q2 FY2024 | Jun 30, 2024 | 92.0% | +224.1 |
| Q1 FY2024 | Mar 31, 2024 | 49.9% | +33.3 |
| Q4 FY2023 | Dec 31, 2023 | 16.5% | −46.7 |
| Q3 FY2023 | Sep 30, 2023 | 89.6% | +4.7 |
| Q2 FY2023 | Jun 30, 2023 | -132.1% | −213.9 |
| Q1 FY2023 | Mar 31, 2023 | 16.6% | −69.0 |
| Q4 FY2022 | Dec 31, 2022 | 63.2% | −24.6 |
| Q3 FY2022 | Sep 30, 2022 | 84.9% | −4.1 |
| Q2 FY2022 | Jun 30, 2022 | 81.8% | −9.1 |
| Q1 FY2022 | Mar 31, 2022 | 85.5% | +1.9 |
| Q4 FY2021 | Dec 31, 2021 | 87.8% | +3.7 |
| Q3 FY2021 | Sep 30, 2021 | 89.0% | +15.7 |
| Q2 FY2021 | Jun 30, 2021 | 90.8% | +15.7 |
| Q1 FY2021 | Mar 31, 2021 | 83.7% | +14.8 |
| Q4 FY2020 | Dec 31, 2020 | 84.1% | +32.7 |
| Q3 FY2020 | Sep 30, 2020 | 73.3% | +22.5 |
| Q2 FY2020 | Jun 30, 2020 | 75.1% | +38.2 |
| Q1 FY2020 | Mar 31, 2020 | 68.9% | −17.8 |
| Q4 FY2019 | Dec 31, 2019 | 51.4% | +38.1 |
| Q3 FY2019 | Sep 30, 2019 | 50.8% | −49.2 |
| Q2 FY2019 | Jun 30, 2019 | 37.0% | −63.0 |
| Q1 FY2019 | Mar 31, 2019 | 86.7% | −13.3 |
| Q4 FY2018 | Dec 31, 2018 | 13.2% | −86.8 |
| Q3 FY2018 | Sep 30, 2018 | 100.0% | +0.0 |
| Q2 FY2018 | Jun 30, 2018 | 100.0% | +12.2 |
| Q1 FY2018 | Mar 31, 2018 | 100.0% | – |
| Q4 FY2017 | Dec 31, 2017 | 100.0% | – |
| Q3 FY2017 | Sep 30, 2017 | 100.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 87.8% | – |
See a number that looks wrong?